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LongevityHuman aging is accompanied by a chronic low-grade inﬂammation,
called “inﬂammaging”, a phenomenon associated with frailty, morbidi-
ty, and mortality in elderly people (Franceschi and Campisi, 2014). This
condition is related to the accumulation of senescent cells in aged
tissues through the senescence-associated secretory phenotype
(SASP), which includes pro-inﬂammatory cytokines among its key
constituents (Franceschi and Campisi, 2014).
A well-known trigger of cellular senescence, closely related to
inﬂammaging, is telomere length shortening. However, while consider-
able evidence shows that circulating inﬂammatory markers are predic-
tors of mortality in community-living elderly individuals (Giovannini
et al., 2011; Varadhan et al., 2014), there are conﬂicting results on the
role of telomere length (Deelen et al., 2014; Bendix et al., 2014).
Arai et al. (2015) in this issue of EbioMedicine demonstrate with a
cross-sectional approach that telomere length, measured in the DNA
extracted from whole blood of centenarian offspring, centenarians and
(semi-)supercentenarians displays a superior maintenance compared
to the one measured in community-living elderly subjects. Indeed,
telomere length of centenarian offspring is maintained for more than
20 years at a length corresponding to 60 years of age in the general
population. Interestingly, the authors observed that while long telo-
meres might be a prerequisite for exceptional lifespan in humans,⁎ Corresponding author at: Nutrition and aging Centre, Scientiﬁc and Technological
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multibiomarker score of systemic inﬂammation, which included anti-
cytomegalovirus IgG, IL-6, TNF-α and C-reactive protein levels, was
associated with an increased risk of mortality, loss of cognitive function
and physical function decline, in normal aging and at extreme old age
(up to 110 years).
These data demonstrate that amultiple biomarker indexmay repre-
sent amore powerful predictor of mortality in older adults than a single
inﬂammatory mediator, as also recently shown through a combined
measure of interleukin 6 (IL-6) and soluble TNF receptor 1 (sTNFR1)
(Varadhan et al., 2014).
Therefore, the development of reliable measures of inﬂammatory
status is of great interest in clinical practice both as risk assessment
tools of age-related chronic diseases, and tomonitor clinical progression
or as a powerful surrogate biomarker in the research of new anti-
inﬂammatory therapeutics.
Hence, given that inﬂammation is a consolidated predictor of mor-
tality, it is also important to investigate the sources of this phenomenon
and their relative contribution. While it is known that cell senescence
and inﬂammation can drive each other thus causing accelerated aging,
the results of Arai and co-workers suggest that blood telomere length
might not reﬂect the phenomenon of accumulation of senescent cells
in various tissues and organs. This could be particularly true if accumu-
lating senescent cells will be conﬁrmed as a major source of circulating
inﬂammatory markers in aging.
The ﬁnding regarding the clearance of p16Ink4a-positive senescent
cells which delay aging-associated disorders in genetically engineered
mice (Baker et al., 2011) opens interesting future perspectives regarding
therapeutic approaches aimedat the removal of senescent cells to prevent
or delay tissue dysfunction and extend healthspan. However, senescent
cells may also exert a physiological role as demonstrated for wound
healing (Demaria et al., 2014) and their clearance could have adverse out-
comes, especially in young organisms. For these reasons it is necessary to
intensify the research effort in order to clarify the effects of the selective
elimination of senescent damaged cells in aged animal models.
In this context, the development of strategies to remove senescent
cells could represent an emerging tool for the suppression of chronic in-
ﬂammation and to ameliorate human healthy lifespan. A feasible and
suggestive approach may be the employment of senolytic compounds
(Zhu et al., 2015), in particular natural bioactive compounds, such as
quercetin, whichmight be easily used in clinical trials, whileminimizing
the risk of adverse events (Malavolta et al., 2015).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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